Skip to main content

Table 1 Patient sample characteristics (n = 314) for 3 MOA groups

From: Effects of mode of administration (MOA) on the measurement properties of the EORTC QLQ-C30: a randomized study

Individual Characteristics Paper & pencil at home
(n = 132)
Telephone
(n = 121)
Paper & pencil in-clinic
(n = 61)
 
  Means (s.d.) Means (s.d.) Means (s.d.) Sig.
Age 56.6(12.9) 57.0(12.0) 54.1(11.5) .30
KPS 77.4(14.4) 78.1(13.7) 78.0(15.0) .93
  N(%) N(%) N(%)  
Sex (%)     
   Male 48(36%) 47(39%) 16(27%) .23
Marital Status     
   Single 11(8%) 9(8%) 6(10%) .92
   Married 99(75%) 97(81%) 44(73%)  
Divorced 10(8%) 7(6%) 5(8%)  
   Widowed 12(9%) 7(6%) 5(8%)  
Education     
   <10 years 70(53%) 69(58%) 32(53%) .21
   10-15 years 39(30%) 35(29%) 12(20%)  
   >15 years 23(17%) 16(13%) 16(27%)  
Employed     
   Yes 50(38%) 41(35%) 19(32%) .70
Stage of Disease*     
   Local/regional 86(66%) 73(61%) 28(47%) .04
Treatment**     
   Chemotherapy 56(42%) 50(41%) 44(73%) <.00
   Radiotherapy 70(53%) 67(55%) 15(25%)  
   RT+CT/other 6(5%) 4(3%) 1(2%)  
Comorbidity     
   Yes 74% 74% 69% .76
Primary Site     
   Breast 48(36%) 49(41%) 32(53%) .11
   Colorectal 38(29%) 31(26%) 10(17%)  
   Lung 36(27%) 29(24%) 9(15%)  
   Other 10(8%) 12(10%) 9(15%)  
  1. * p < 0.05 ** p < 0.01